Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
14.98
-0.66 (-4.22%)
At close: Apr 1, 2025, 4:00 PM
15.17
+0.19 (1.25%)
After-hours: Apr 1, 2025, 7:55 PM EDT

Arcutis Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
1,7771,6303059011,0431,225
Upgrade
Market Cap Growth
434.82%434.82%-66.18%-13.58%-14.88%-
Upgrade
Enterprise Value
1,6601,5082836266811,039
Upgrade
Last Close Price
14.9813.933.2314.8020.7428.13
Upgrade
PS Ratio
9.228.305.11244.56--
Upgrade
PB Ratio
11.2110.353.444.303.504.53
Upgrade
P/TBV Ratio
11.0111.013.714.453.504.53
Upgrade
EV/Sales Ratio
8.457.674.75169.88--
Upgrade
Debt / Equity Ratio
0.700.702.320.970.260.02
Upgrade
Asset Turnover
0.570.570.150.01--
Upgrade
Inventory Turnover
1.381.380.48---
Upgrade
Quick Ratio
3.723.726.3811.0611.6112.61
Upgrade
Current Ratio
4.144.147.0811.5712.0912.96
Upgrade
Return on Equity (ROE)
-113.76%-113.76%-175.79%-122.80%-72.62%-72.93%
Upgrade
Return on Assets (ROA)
-23.25%-23.25%-38.12%-43.97%-36.55%-42.14%
Upgrade
Return on Capital (ROIC)
-28.52%-28.52%-42.64%-47.89%-39.67%-45.26%
Upgrade
Earnings Yield
-7.88%-8.59%-85.99%-34.55%-19.78%-11.07%
Upgrade
FCF Yield
-6.32%-6.89%-81.18%-28.63%-16.84%-9.25%
Upgrade
Buyback Yield / Dilution
-74.53%-74.53%-25.94%-11.39%-38.52%-1835.11%
Upgrade
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q